Abstract
The synthesis of two novel glycero-3-phosphoinositol ether lipid analogues, rac-l-O-octadecyl-2-O methylglycero-3-phospho-myo-inositol 6 (an ether lipid analogue of rac-l-O-octadecyl-2-O-methylglycero-3-phosphocholine; ET-18-OMe) and rac-l-O-octadecyl-2-O-acetylglycero-3-phospho-myo-inositol 11 (an ether lipid analogue of platelet-activating factor), is described. The two target compounds and the synthetic intermediates were evaluated for inhibition of HL60, BG1, and BG3 human malignant cells in vitro and inhibition of protein kinase C. Tumor inhibitory activity was found for compounds 6 and 11 in all systems but not for their synthetic intermediates. However, compounds 6 and 11 as well as the synthetic intermediates 5 and 13, but not 9, exhibited protein kinase C inhibitory activity.
Similar content being viewed by others
REFERENCES
T.-C. Lee, and F. Snyder. In J. F. Kuo (ed.), Phospholipids and Cellular Regulation, CRC Press, Boca Raton, Fla., 1985, Vol. II, pp. 2–39.
W. E. Berdel, R. Andreesen, and P. G. Munder. In J. F. Kuo (ed.) Phospholipids and Cellular Regulation, CRC Press, Boca Raton, Fla., 1985, Vol. II, pp. 41–73.
W. E. Berdel and P. G. Munder. Antineoplastic actions of ether lipids related to platelet-activating factor. In F. Snyder (ed.), Platelet-Activiting Factor and Related Lipid Mediators, Plenum Press, New York, 1987, pp. 449–467.
E. J. Modest, L. W. Daniel, R. L. Wykle, M. E. Berens, C. Piantadosi, J. R. Surles, and S. Morris-Natschke. In K. Harrap and T. Connors (eds.), New Avenues in Developmental Cancer Chemotherapy, Bristol-Myers Cancer Symposia, Academic Press, New York, 1987, Vol. 8, pp. 387–400.
J. T. O'Flaherty, R. L. Wykle, C. H. Miller, J. C. Lewis, M. Waite, D. A. Bass, C. E. McCall, and L. R. DeChatelet. Am. J. Pathol. 103:70–78 (1981).
P. G. Munder, M. Modolell, W. Bausert, H. F. Oettgen, and O. Westphal. In E. M. Hersh, M. A. Chirigos, and M. J. Mastrangelo (eds.), Augmenting Agents in Cancer Therapy, Raven Press, New York, 1981, pp. 441–458.
D. N. Helfman, K. C. Baines, J. M. Kinkade, W. R. Vogler, M. Shoji, and J. F. Kuo. Cancer Res. 43:2955–2961 (1983).
J. Parker, L. W. Daniel, and M. Waite. J. Biol. Chem. 262: 5385–5393 (1987).
L. W. Daniel, L. A. Etkin, B. T. Morrison, J. Parker, S. Morris-Natschke, J. R. Surles, and C. Piantadosi. Lipids 22:851–855 (1987).
M. Modolell, R. Andreesen, W. Pahlke, U. Brugger, and P. G. Munder. Cancer Res. 39:4681–4686 (1979).
D. B. J. Herrmann. J. Natl. Cancer Inst. 75:423–430 (1985).
Y. Honma, T. Kasukabe, M. Hozumi, S. Tsushima, and H. Nomura. Cancer Res. 41:3211–3216 (1981).
G. Storme, W. E. Berdel, W. J. van Blitterswijk, E. A. Bruyneel, G. K. DeBruyne, and M. M. Mareel. Cancer Res. 45:351–357 (1985).
W. J. van Blitterswijk, H. Hilkmann, and G. A. Storme. Lipids 22:820–823 (1987).
A. Noseda, J. G. White, and E. J. Modest. Proc. Am. Assoc. Cancer Res. 28:13 (1987).
A. Noseda, P. L. Godwin, and E. J. Modest. Biochim. Biophys. Acta 945:92–100 (1988).
A. Noseda, J. G. White, P. L. Godwin, W. G. Jerome, and E. J. Modest. Exp. Mol. Pathol. (in press).
A. Noseda, P. L. Godwin, and E. J. Modest. Proc. Am. Assoc. Cancer Res. 29:321 (1988).
S. Morris-Natschke, J. R. Surles, L. W. Daniel, M. E. Berens, E. J. Modest, and C. Piantadosi. J. Med. Chem. 29:2114–2117 (1986).
M. H. Marx, C. Piantadosi, A. Noseda, L. W. Daniel, and E. J. Modest. J. Med. Chem. 31:858–863 (1988).
A. Noseda, M. E. Berens, C. Piantadosi, and E. J. Modest. Lipids 22:878–883 (1987).
M. J. Berridge. Annu. Rev. Biochem. 56:159–193 (1987).
A. Kishimoto, Y. Takai, T. Mori, U. Kikkawa, and Y. Nishizuka. J. Biol. Chem. 255:2273–2276 (1980).
R. Gigg and C. D. Warren. J. Chem. Soc. C 2367–2371 (1969).
A. Hermetter, F. Paltauf, and H. Hauser. Chem. Phys. Lipids 30:35–45 (1982).
S. S. Yang, T. R. Beattie, and T. Y. Shen. Tetrahedron Lett. 23:5517–5520 (1982).
J. R. Surles, R. L. Wykle, J. T. O'Flaherty, W. L. Salzer, F. Snyder, and C. Piantadosi. J. Med. Chem. 38:73–78 (1985).
B. A. Stoochnoff and N. L. Benoiton. Tetrahedron Lett. 1:21–24 (1973).
A. J. E. Porck and B. M. Craig. Can. J. Chem. 33:1286–1289 (1955).
E. J. Corey, J. L. Gras, and P. Ulrich. Tetrahedron Lett. 11: 809–812 (1976).
W. J. Baumann and H. K. Mangold. J. Org. Chem. 29:3055–3057 (1967).
C. E. Welander, T. M. Morgan, H. D. Homesley, P. P. Trotta, and R. J. Spiegel. Int. J. Cancer 35:721–729 (1985).
A. W. Hamburger and S. E. Salmon. Science 197:461–463 (1977).
R. W. Wilcox, R. L. Wykle, J. D. Schmitt, and L. W. Daniel. Lipids 22:800–807 (1987).
W. J. van Blitterswijk, R. L. van der Bend, I. J. M. Kramer, A. J. Verhoeven, H. Hilkmann, and J. de Witt. Lipids 22:842–846 (1987).
L. W. Daniel, G. W. Small, J. D. Schmitt, C. J. Marasco, K. S. Ishaq, and C. Piantadosi. Biochem. Biophys. Res. Commun. 151:291–297 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ishaq, K.S., Capobianco, M., Piantadosi, C. et al. Synthesis and Biological Evaluation of Ether-Linked Derivatives of Phosphatidylinositol. Pharm Res 6, 216–224 (1989). https://doi.org/10.1023/A:1015961416370
Issue Date:
DOI: https://doi.org/10.1023/A:1015961416370